secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K/A
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001437749-25-038544
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences amends 8-K to report Dawn Bir appointed to Compensation Committee
--------------------------------------------------------------------------------

- Dawn C. Bir appointed to Compensation Committee effective December 18, 2025.
- Amendment to prior 8-K filed October 22, 2025 reporting her board appointment.
- No other changes to the original current report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/0001437749-25-038544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774925038544/sava20251219_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-038544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer